碱性成纤维细胞生长因子调节小鼠MHC单倍体造血干细胞移植后急性移植物抗宿主病的实验分析-内科学(血液病)专业论文.docxVIP

碱性成纤维细胞生长因子调节小鼠MHC单倍体造血干细胞移植后急性移植物抗宿主病的实验分析-内科学(血液病)专业论文.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
第三军医大学硕士学位论文 第三军医大学硕士学位论文 PAGE PAGE 10 PBS phosphate buffered solution 磷酸盐缓冲溶液 TNF-α tumor necrosis factor-α 肿瘤坏死因子-α TBI total body irradiation 全身照射 Study of bFGF preventing Acute GVHD in Murine Haploidentical Hematopoietic Stem Cell Transplantation Model Abstract Background and Objective: Hematopoietic stem cell transplantation (HSCT) is an effective method which can cure a variety of hematologic malignancies. However, For many patients we can not find a full-matched donor or only one locus mismatched related donors. In high risk patients , haploidentical donors are suitable alternatives.. Haploidentical stem cell transplantation has become an effective method for treatment of hematologic malignancies in recent years since we can easily get haploidentical donors from parents or child . Compared with full-matched transplantation, the GVHD (Graft-versus-host disease) is the main obstacle for the haploidentical hematopoietic stem cell transplantation (haplo-HSCT). The occurrence of a-GVHD after haplo-HSCT was reported from 50% to 80%, and the transplant-related mortality rate was 30% , which seriously affected the survival time and the quality of life .,And it is the main causes why haplo-HSCT can’t be widely apllied. In this study we want to find a new way to decrease the occurrence of a-GVHD after haplo-HSCT so as to decrease the complication and mortality rate of haplo-HSCT. The prevention methods for GVHD after Haplo-HSCT is mainly consist of removal of T cells in vitro, CD34 sorting, strengthing conditioning regimen and strengthing immune suppression taking. However, all the above methods have the disadvantages of high incidence of infection rate、recurrence rate、and transplant- related mortality rate. In recent years, cell therapy as a-GVHD prevention method in experimental study and clinical application got satisfactory effective, and the bone marrow-derived mesenchymal stem cells to prevent the effects of GVHD has been widely recognized. Prese

您可能关注的文档

文档评论(0)

peili2018 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档